Latest Cover Story
Click here for PDF Flipbook
Research shows that ankle health plays a role in the recruitment of the muscles around it. Millions of people sprain their ankles each year, from athletes to weekend warriors to vacationers stepping off the curb wrong. The injury is common, and for most people, treatable with ice, painkillers, and rest.
By Nicole Wetsman
A REVIEW FOR LOWER-EXTREMITY SPECIALISTS: Mitigating the Opioid Crisis with Pain Management Regimens in a Multimodal Approach
An Introduction to Physical Literacy
Physical literacy is defined as ‘the motivation, confidence, physical competence, knowledge and understanding to value and take responsibility for engagement in physical activities for life.’*
The notion of ‘literacy’ within the concept of ‘physical literacy’ arises from the importance of our embodied interaction with the world. It is accepted that we have a range of capabilities such as musical, literary, mathematical, etc., which can be developed. We all have an embodied potential and it is important that policies and mechanisms which are influential in providing opportunities to promote physical activity are coordinated, so that individuals can develop physical literacy throughout their lives. Physical literacy differs from most other literacies in its concern for the affective dimension, ie, motivation and confidence, and its focus on lifelong valuing and personal responsibility. However, it shares reference to the application of skills and knowledge and understanding with most others. Through maximizing movement opportunities during the early years, expanding experience in varied environments throughout formal schooling and providing opportunities throughout life to engage in physical activity, everyone has the potential to make progress on their physical literacy journey. Overcoming adversity or injury is also key to making progress and, as such, the healthcare profession has a huge role to play in supporting the development of physical literacy.
By E.J. Durden-Myers and N. R. Green
3D-printed Sockets Safe? There are approximately 2 million people living with an amputation in the United States, a number that is expected to increase to 3.6 million by 2050 according to recent studies. In the poster, “Clinical Trial Examining Safety and Feasibility of Definitive 3D-Printed…
By Keith Loria
Congenital talipes equinovarus, or clubfoot, is a common deformity in which the affected foot is fixed downward and inward. The birth prevalence of clubfoot in low- and middle-income countries is estimated to be 0.5 to 2.0 cases for every 1000 live births.
There is a global trend toward use of the minimally invasive Ponseti method for the correction of clubfoot, consisting of simultaneous correction of the components of the clubfoot deformity ...
Studies seeking to determine the effects of gait retraining through biofeedback on peak tibial acceleration (PTA) assume that this biometric trait is a valid measure of impact loading that is reliable both within and between sessions. However, data was lacking for the validity and reliability of these measures at the speed of endurance runners.
By Pieter Van den Berghe
The Diabetic Foot Global Conference (DFCon2019) will be held at the Hilton Los Angeles/Universal City in Los Angeles, California, USA, Oct. 17-19, 2019. All those engaged in the field of diabetic foot care, wound healing, limb salvage, and amputation…
Physical activity reduces the risk of many chronic illnesses and increases the odds of a longer, healthier life. But it hasn’t been clear whether the benefits of exercise differ based on when during their lives people are most active.
By Sharon Reynolds
Over 30 million Americans have diabetes and 1.5 million Americans are newly diagnosed with diabetes each year. Peripheral neuropathy (PN) is a major diabetic complication and affects 30% to 50% of people with diabetes. Diabetic peripheral neuropathy (DPN) is a leading cause of devastating outcomes such as foot ulcer and amputation.
By Bijan Najafi and Gu Eon Kang
Industry News & Updates
The US Food & Drug Administration (FDA) has approved a new treatment for osteoporosis in postmenopausal women presenting with a high risk of fracture or who are intolerant to or have not had success with existing therapies. The drug, EVENITY (romosozumab-aqqg; Amgen), was approved April 9 and became available for shipment to wholesalers in the US on April 15.